Regan MM, Catalano PJ. Likelihood models for clustered binary and continuous outcomes: Application to developmental toxicology. Biometrics 1999; 55:760-768.
Regan MM, Catalano PJ. Bivariate dose-response modeling and risk estimation in developmental toxicology. Journal of Agricultural, Biological and Environmental Statistics 1999; 4:217-237.
Regan MM, Catalano PJ. Regression models for mixed discrete and continuous outcomes with clustering. Risk Analysis 2000; 20(3):363-376.
Coull B, Catalano PJ, Godleski J. Semiparametric analyses of cross-over data with repeated measures. Journal of Agricultural, Biological and Environmental Statistics 2000; 5(4):417-429.
Watanabe T, Wu Tsung-Teh, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB, Hamilton SR. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. New England Journal of Medicine 2001; 344:1196-206.
Geys H, Regan MM, Catalano PJ, Molenberghs G. Two latent variable risk assessment approaches for mixed continuous and discrete outcomes from developmental toxicity data. Journal of Agricultural, Biological, and Environmental Statistics 2001; 6(3):340-355.
Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson II AB. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. J Clin Oncol 2002; 20(15):3270-3275.
Marsh JC, Catalano P, Huang J, Graham DL, Cornfeld MJ, O’Dwyer PJ, Benson AB. Eastern Cooperative Oncology Group Phase II Trial (E4296) of oral 5-Fluorouracil and Eniluracil as a 28-day regimen in metastatic colorectal cancer. Clinical Colorectal Cancer 2002; 2(1):43-50.
Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB III, Fuchs CS. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003; 21:433-440.
Johnston PG, Benson III AB, Catalano P, Sambasiva Rao M, O’Dwyer PJ, Allegro CJ. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. J Clin Oncol 2003; 21(5):815-819.
Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson III AB, Macdonald JS, Fuchs CS. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003; 98:484-495.
Walker KD, Catalano P, Hammitt JK, Evans JS. Use of expert judgment in exposure assessment: Part 2. Calibration of expert judgments about personal exposures to benzene. J Exposure Analysis and Environmental Epi 2003; 13:1-16.
Yeap BY, Catalano PJ, Ryan LM, Davidian M. A robust two-stage approach to repeated measurements analysis of chronic ozone exposure in rats. Journal of Agricultural, Biological and Environmental Statistics 2003; 8:438-454.
Meyerhardt JA, Catalano PJ, Schrag D, Ayanian JZ, Haller DG, Mayer RJ,
Macdonald JS, Benson III AB, Fuchs CS. Association of hospital
procedure volume and outcomes in high-risk curatively resected colon
cancer. Ann Int Med 2003; 139:649-657
Rojas-Bracho L, Suh HH, Catalano P, Koutrakis P. Personal PM2.5 and PM10 exposures of COPD patients living in Boston and their relationship to their personal activities. Journal of Air and Waste Management 2004; 54(2):207-217.
Han KE, Catalano PJ, Senchaudhuri P, Mehta C. Exact analysis of dose-response for multiple correlated binary outcomes. Biometrics 2004; 60:216-224.
Benson AB, Catalano PJ. A rose, is a rose, is a rose…or not. J Clin Oncol 2004; 22(10): 1773-1775.
Chirieac L, Shen L, Catalano P, Issa J-P, Hamilton SR. Phenotype of microsatellite-stable colorectal carcinomas with CpG island methylation. Am J Surg Path 2005; 29(4):429-436.
Rich DQ, Schwartz J, Mittleman MA, Link M, Luttman-Gibson H, Catalano PJ, Speizer FE, Dockery DW. Association of short-term ambient air pollution concentrations and ventricular arrhythmias. Am J Epidemiol 2005; 161(12):1123-1132.
Cohen SJ, Dobelbower R, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-c in patients with locally advanced adenocarcinoma of the pancreas: ECOG study E8282. Int J Radiation Oncology Biol Phys 2005; 62(5):1345-1350.
Sun W, Lipsitz S, Catalano P, Mailliard JA, Haller DG. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group study E1281. J Clin Oncol 2005; 23(22):4897-4904.
Yu Z-F, Catalano PJ. Quantitative risk assessment for bivariate continuous outcomes with application to neurotoxicology: the bivariate case. Biometrics 2005; 61:757-766.
Haller DG, Catalano PJ, Macdonald JS, O’Rourke MA, Frontiera MS, Jackson DV, Mayer RJ. Phase III study of fluorouracil, leucovorin and levamisole in high-risk stage II and III colon cancer: final report of INT-0089. J Clin Oncol 2005; 23:8671-8678.
Sargent DJ, Wieand S, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O’Callaghan CJ, Francini G, Grothey A, O’Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A. Disease-free survival (DFS) vs. overall survival (OS) as a primary endpoint for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2005; 23:8664-8670.
Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Onocl 2005; 23:8706-8712.
Rich DQ, Mittleman MA, Link M, Schwartz J, Luttman-Gibson H, Catalano PJ, Speizer FE, Gold DR, Dockery DW. Increased risk of paroxysmal atrial fibrillation episodes associated with acute increases in ambient air-pollution. EHP 2006; 114:120-123.
Rich DQ, Kim MH, Turner JR, Mittleman MA, Schwartz J, Catalano PJ, Dockery DW. Association of ventricular arryhythmias detected by implantable carioverter defibrillator and ambient air pollutants in the St Louis, Missouri metropolitan area. Occup Environ Med 2006; 63:591-596.
Jhawer M, Mani S, Lefkopoulou M, Hahn RG, Harris J, Catalano PJ, Haller D. Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and bleomycin-CCNU in patients with advanced cancer of the anal canal: an eastern cooperative oncology group study E7282. Invest New Drugs 2006; 24:447-454.
Giantonio BJ, Levy DE, O’Dwyer PJ, Meropol NJ, Catalano PJ, Benson AB 3rd. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. Ann Oncol 2006; 17(9):1399-1403.
Miller KL, Karagas MR, Kraft P, Hunter DJ, Catalano PJ, Byler SH, Nelson HN. XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis 2006; 27(8):1670-1675.
Malin JL, Ko C, Ayanian JZ, Harrington D, Nerenz DR, Kahn KL, Ganther-Urmie J, Catalano PJ, Zaslavsky AM, Wallace RB, Guadagnoli E, Arora NK, Roudier MD, Ganz PA. Understanding cancer patients’ experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 2006; 14(8):837-848
Nikolov MC, Coull BA, Catalano PJ, Godleski JJ. An informative Bayesian structural equation model to assess source-specific health effects of air pollution. Biostatistics 2007; 8(3):609-624.
Giantonio BJ, Catalano PJ, Meropol NJ, O’Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB III. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007; 25:1539-1544.
George EO, Armstrong D, Catalano PJ, Srivastava DK. Regression models for analyzing clustered binary and continuous outcomes under an assumption of exchangeability. Journal of Statistical Inference and Planning 2007; 137:3462-3474.
Applebaum KM, Karagas MR, Hunter DJ, Catalano PJ, Byler SH, Morris S, Nelson HN. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. EHP 2007; 115(8):1231-1236.
Breton CV, Kile ML, Catalano PJ, Hoffman E, Quamruzzaman Q, Rahman M, Mahiuddin G, Christiani DC. GSTM1 and APE1 genotypes affect arsenic-induced oxidative stress: a repeated measures study. Environ Health 2007;6:39.
Najita J, Li Y, Catalano PJ. A novel application of a bivariate regression model for binary and continuous outcomes to studies of fetal toxicity. Applied Statistics 2008. In press.